This inventor holds 1 USPTO granted patent. Top assignee: Zhejiang Doer Biologics Corporation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Xuelian Wang: Innovator in Fusion Protein Technology
Introduction: Xuelian Wang is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins aimed at treating intestinal diseases. His innovative work has garnered attention in the scientific community.
Latest Patents: Xuelian Wang holds 1 patent for his invention titled "Fusion protein for treating intestinal diseases." This invention provides fusion proteins with a specific structure: R-L-P, where R is a GLP-2 receptor agonist, L is a peptide linker, and P is a long-acting carrier protein. The fusion protein demonstrates significant bioactivities and in vitro stability, showcasing its potential for therapeutic applications.
Career Highlights: Wang is currently associated with Zhejiang Doer Biologics Corporation, where he continues to advance his research and development efforts. His work at the company emphasizes the importance of innovative solutions in the treatment of gastrointestinal disorders.
Collaborations: Xuelian Wang collaborates with talented individuals in his field, including Xiaofang Wen and Yanshan Huang. These partnerships enhance the research environment and contribute to the success of their projects.
Conclusion: Xuelian Wang's contributions to the field of biotechnology, particularly through his patent on fusion proteins, highlight his role as an innovator. His work has the potential to impact the treatment of intestinal diseases significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile